Distinct TNF-alpha and HLA polymorphisms associate with fibrotic and non-fibrotic subtypes of hypersensitivity pneumonitis C. Freitas; B. Lima; N. Melo; P. Mota; H. Novais-Bastos; H. Alves; O. Sokhatska; L. Delgado; A. Morais;

Drug reaction with eosinophilia and systemic symptoms syndrome associated with osimertinib S.C. Ferreira; C. Gaspar; J. Dionísio; C. Moura; T. Almodovar;

Results from phase II, open-label study of anti-tumoral activity of first-line erlotinib in advanced/metastatic NSCLC patients with EGFR activating mutations, in Portugal: The MuTAR study F. Barata; H. Queiroga; E. Teixeira; T. Almodovar; M. Soares; B. Parente; J.C. Mellidez; P. Alves; A. Antunes;